2018 Safety Pharmacology Society West Coast Regional Meeting

2018 Safety Pharmacology Society West Coast Regional Meeting 2018-11-12T17:35:02+00:00

AnaBios is proud to co-sponsor the 2018 Safety Pharmacology Society West Coast Regional Meeting, to be held in Foster City, California at the corporate headquarters of Gilead. Other co-sponsors of the event include Calvert Laboratories, Gilead and NeuCyte.

This year’s theme is “Filling Translational Gaps in Safety Assessment.”

AGENDA

8:30 AM – Registration & continental breakfast (sponsored by Gilead)

8:50 AM – Opening remarks and introductions by Chris Mathes, AnaBios

9:00 AM – Keynote lecture by Dr. Philip Sager, Stanford University School of Medicine

Session 1

9:45 – 10:15 AM –Ray Chui, Amgen – “Pro‐Arrhythmia Evaluation in a Dog Model of HF: Augmenting the Nonclinical Tool Box”

10:15 – 10:45 AM – Najah Abi-Gergis, AnaBios – “Preclinical Human Contractility Safety Testing”

10:45 – 11:15 AM – Networking coffee break (sponsored by DSI)

11:15 – 11:45 AM – Todd McDevitt, Gladstone Institutes – “Engineering of Human Tissue Constructs from Pluripotent Stem Cells”

Session 2

11:45 – 12:15 PM – Carrie McMahon, Gilead – “CV Risk Assessment in Radiotelemetry-Instrumented Male Cynomolgus Monkeys Following Oral Administration of a Multi-Kinase Inhibitor”

12:15 – 12:45 PM – Lorena Saavedra, NeuCyte – “Predicting Seizure Liabilities in a Dish Using Human iPSC-based Neural Cells”

12:45 – 2:00 PM – Lunch (sponsored by Calvert Laboratories)

2:00 – 2:30 PM – Joseph Wu, Stanford University School of Medicine – “Stem Cells & Genomics for Precision Medicine”

Session 3

2:30 – 3:00 PM – Johanna Schaub, Pliant Therapeutics, Inc. – “Utilization of Precision Cut Tissue Slices to Evaluate Integrin Inhibition for the Treatment of Fibrosis”

3:00 – 3:30 PM – Carlos del Rio, MyoKardia – “Leveraging Large Animal Models of Inherited Cardiomyopathy in Pre-Clinical Pharmacology: The Missing Piece”

3:30 – 4:00 PM – Networking coffee break (sponsorship available)

4:00 – 4:30 PM – Dale Stevens, Genentech – “Nonclinical Cardiovascular Assessment of Small Molecule DNA-1”

Session 4

4:30 – 5:00 PM – Hugo Vargas, Amgen – “Translation of Safety Pharmacology Testing to Human Trials:  What Do We Know?”

5:00 – 7:00 PM – Networking reception (sponsorship available)